Matthew Strobeck, Director at Yield10 Bioscience, holds 325.24K shares in Accelerate Diagnostics (Ticker: AXDX), holds 5.01M shares in Biodesix (Ticker: BDSX), holds 65.20K shares in QuidelOrtho (Ticker: QDEL).
What is the percentage of profitable transactions made by Matthew Strobeck?
The percentage of profitable transactions made by Matthew Strobeck is 57%.
What is the average return per transaction made by Matthew Strobeck?
The average return per transaction made by Matthew Strobeck is -0.10%.
What stocks does Matthew Strobeck hold?
Matthew Strobeck holds: YTEN, AXDX, QDEL, BDSX, SNTS stocks.
What was Matthew Strobeck’s latest transaction?
Matthew Strobeck latest transaction was an Uninformative Buy of ―.
What was Matthew Strobeck's most profitable transaction?
Matthew Strobeck’s most profitable transaction was an Informative Buy of AXDX stock on March 20, 2020. The return on the trade was 101.00%.
What is Matthew Strobeck's role in Yield10 Bioscience?
Matthew Strobeck's role in Yield10 Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.